New study tailors fertility-saving cancer therapy to tumor type

NCT ID NCT07319429

First seen Jan 11, 2026 · Last updated Jun 15, 2026 · Updated 31 times

Summary

This study aims to improve fertility-sparing treatment for young women with endometrial cancer by using the tumor's genetic profile to choose the best therapy. About 260 participants will receive treatments matched to their cancer subtype, such as hormone therapy or immunotherapy. The goal is to increase the chance of eliminating the cancer while preserving the uterus for future pregnancy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Shanghai Tenth People's Hospital

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, 200090, China

  • Shanghai Tenth People's Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 200090, China

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.